Apixaban or Enoxaparin After Head and Neck Cancer Surgery
Phase 4
76
about 2.2 years
18–89
1 site in NY
What this study is about
Researchers are testing if apixaban (a pill) can be used instead of enoxaparin (a shot) to prevent blood clots after head and neck cancer surgery. The trial will also look at how easy it is for patients to take apixaban compared to enoxaparin, and whether they stick with the treatment plan. Participants will take either apixaban or enoxaparin for 10 days after surgery, keep track of their medication, and have regular checkups.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Apixaban
- 2.Take Enoxaparin
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You are randomly assigned, but you will know your treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
apixaban (Factor Xa inhibitor; prevents clot formation), enoxaparin (Low molecular weight heparin; inactivates clotting factor Xa)
oral, injection
Oncology